Thomas Bumol

Thomas Bumol

Director/Miembro de la Junta en OMEROS CORPORATION .

Fortuna: 95 100 $ al 30/06/2026

72 años
Health Technology
Commercial Services
Consumer Services

Perfil

Thomas F.
Bumol
is currently an Independent Director at Omeros Corp.
since 2019, a Director at Revalesio Corp.
since 2020, a Director at Spine BioPharma, Inc., an Independent Director at Tentarix Biotherapeutics LP since 2022, and a Venture Partner at Samsara BioCapital LLC starting in 2026.
Formerly, Dr. Bumol was a Director at PanTheryx, Inc., Executive Director & Executive Vice President at Allen Institute For Immunology from 2018 to 2022, Senior VP-Biotechnology & Autoimmunity Research at Eli Lilly & Co. from 2015 to 2017, President at Applied Molecular Evolution, Inc., and Vice President-Research Technologies & Proteins at Lilly Research Laboratories from 2001 to 2012.
Education includes an undergraduate degree from the University of Michigan in 1975 and a doctorate from the University of Minnesota in 1980.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
18/06/2026 10.000 ( 0,01 % ) 95 100 $ 30/06/2026

Cargos activos de Thomas Bumol

EmpresasCargoInicio
OMEROS CORPORATION Director/Miembro de la Junta 09/02/2019
Director/Miembro de la Junta 01/10/2020
Director/Miembro de la Junta 20/05/2022
Director/Miembro de la Junta -
Inversor de Capital Privado 01/01/2026

Antiguos cargos conocidos de Thomas Bumol.

EmpresasCargoFin
Director/Miembro de la Junta 01/08/2022
ELI LILLY AND COMPANY Director Técnico/Científico/I+D 01/12/2017
Director/Miembro de la Junta -
Director Técnico/Científico/I+D -
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░ -
Ver el detalle de la experiencia de Thomas Bumol.

Formación de Thomas Bumol.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

83

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Finance

Commercial Services

Health Technology

Health Technology